Alto Neuroscience Newsroom

Alto Neuroscience Analyst Ratings

BenzingaNov 13 23:20

Stifel Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Cuts Target Price to $10

Futu NewsNov 13 21:31

TD Cowen Maintains Alto Neuroscience(ANRO.US) With Buy Rating

Futu NewsNov 13 19:31

Alto Neuroscience Price Target Cut to $4.00/Share From $29.00 by Wedbush

Dow JonesOct 23 23:30

Alto Neuroscience Cut to Neutral From Outperform by Wedbush

Dow JonesOct 23 23:30

Alto Neuroscience Stock Crashes Amid Failed Study, Wedbush Downgrade

Seeking AlphaOct 23 22:56

Stifel Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $32

Futu NewsOct 23 20:31

Alto Neuroscience, Inc. (ANRO) Gets a Buy From Stifel Nicolaus

TipRanksOct 23 19:39

Baird Maintains Outperform on Alto Neuroscience, Lowers Price Target to $10

BenzingaOct 23 19:27

Alto Neuroscience Analyst Ratings

BenzingaOct 23 19:25

Baird Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $32

Futu NewsSep 11 15:31

Buy Rating Affirmed for Alto Neuroscience, Inc. Amid Promising ALTO-100 Clinical Developments

TipRanksSep 11 14:40

Alto Neuroscience Price Target Maintained With a $29.00/Share by Wedbush

Dow JonesSep 10 21:03

Alto Neuroscience Analyst Ratings

BenzingaSep 10 20:52

Wedbush Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $29

Futu NewsSep 10 20:31

TD Cowen Maintains Alto Neuroscience(ANRO.US) With Buy Rating

Futu NewsSep 10 19:31

Analysts Are Bullish on These NA Stocks: Alto Neuroscience, Inc. (ANRO), Rubrik, Inc. Class A (RBRK)

TipRanksSep 10 19:23

Wedbush Initiates Alto Neuroscience(ANRO.US) With Buy Rating, Announces Target Price $29

Futu NewsSep 4 18:34

Jefferies Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $33

Futu NewsAug 26 22:31

Buy Rating Affirmed for Alto Neuroscience, Inc. on Strong Clinical Trials and Strategic Precision Neuroscience Approach

TipRanksAug 16 14:29